"You need an incentive to invest" according to AstraZeneca boss

By Rich Wilcock

10th Feb 2023 | Healthcare

The Chief Executive of AstraZeneca has blamed the high corporation tax rate as the reason for the company's switch from building their new £330 million manufacturing facility in Macclesfield.

The comments come after AstraZeneca revealed promising full-year results and strong growth in some areas yesterday (February 09th)

Sir Pascal Soriot said "'We want to invest in the UK but we need to see supporting policies for the whole industry. You need an environment that gives you good returns and an incentive to invest."

AstraZeneca's factory in Macclesfield

The facility which was hoped to bring 200 jobs to the area will now be built in Blanchardstown, Dublin.

Sir Soriot said that a lower corporation tax would be needed but was 'unfortunately going up'

The Government announced in November that corporation tax was going up from 19% to 25% from April.

The news of AstraZeneca switch to Ireland comes after new figures showed that the U.K avoided falling into recession in 2022, with zero growth between October and December.

The office of national statistics also revealed that the North West's unemployment rate was slightly above the current national average at 3.8% but productivity in the region followed the national trend and remained stagnant.


Related Articles


Alderley Park development looks set to be approved

Spectrum's David Killengrey (image - nub news)

Ophthalmic company, based in Cheshire to launch new products as it eyes company growth in 2023

Sign-Up for our FREE Newsletter

We want to provide Congleton with more and more clickbait-free local news.
To do that, we need a loyal newsletter following.
Help us survive and sign up to our FREE weekly newsletter.

Already subscribed? Thank you. Just press X or click here.
We won't pass your details on to anyone else.
By clicking the Subscribe button you agree to our Privacy Policy.